Global Drug-Eluting Bioabsorbable Stents Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report ID: GIR2201100299 | Category: Medical Devices & Consumables | Pages: 100 | Format: PDF | Published Date: July 27,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Drug-Eluting Bioabsorbable Stents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Drug-Eluting Bioabsorbable Stents market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during review period. Coronary Artery Diseases accounting for % of the Drug-Eluting Bioabsorbable Stents global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Serolimus and Paclitaxel Drug-Eluting Stents segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Drug-Eluting Bioabsorbable Stents include Medtronic, B.Braun Melsungen, Abbott Laboratories, Boston Scientific Corporation, and Biosensors International, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Drug-Eluting Bioabsorbable Stents market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Serolimus and Paclitaxel Drug-Eluting Stents
    Sirolimus Drug Eluting Stents
Market segment by Application can be divided into
    Coronary Artery Diseases
    Peripheral Artery Diseases
The key market players for global Drug-Eluting Bioabsorbable Stents market are listed below:
    Medtronic
    B.Braun Melsungen
    Abbott Laboratories
    Boston Scientific Corporation
    Biosensors International
    Terumo Corporation.
    MicroPort Scientific Corporation
    Alvimedica
    Biotronik
    Elixir Medical Corporation
    Innovative Health Technologies
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drug-Eluting Bioabsorbable Stents product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drug-Eluting Bioabsorbable Stents, with price, sales, revenue and global market share of Drug-Eluting Bioabsorbable Stents from 2019 to 2022.
Chapter 3, the Drug-Eluting Bioabsorbable Stents competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drug-Eluting Bioabsorbable Stents breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Drug-Eluting Bioabsorbable Stents market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug-Eluting Bioabsorbable Stents.
Chapter 13, 14, and 15, to describe Drug-Eluting Bioabsorbable Stents sales channel, distributors, customers, research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Drug-Eluting Bioabsorbable Stents Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Drug-Eluting Bioabsorbable Stents Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Serolimus and Paclitaxel Drug-Eluting Stents
        1.2.3 Sirolimus Drug Eluting Stents
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Drug-Eluting Bioabsorbable Stents Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Coronary Artery Diseases
        1.3.3 Peripheral Artery Diseases
    1.4 Global Drug-Eluting Bioabsorbable Stents Market Size & Forecast
        1.4.1 Global Drug-Eluting Bioabsorbable Stents Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Drug-Eluting Bioabsorbable Stents Sales in Volume (2017-2028)
        1.4.3 Global Drug-Eluting Bioabsorbable Stents Price (2017-2028) 
    1.5 Global Drug-Eluting Bioabsorbable Stents Production Capacity Analysis
        1.5.1 Global Drug-Eluting Bioabsorbable Stents Total Production Capacity (2017-2028)
        1.5.2 Global Drug-Eluting Bioabsorbable Stents Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Drug-Eluting Bioabsorbable Stents Market Drivers
        1.6.2 Drug-Eluting Bioabsorbable Stents Market Restraints
        1.6.3 Drug-Eluting Bioabsorbable Stents Trends Analysis
2 Manufacturers Profiles
    2.1 Medtronic
        2.1.1 Medtronic Details
        2.1.2 Medtronic Major Business
        2.1.3 Medtronic Drug-Eluting Bioabsorbable Stents Product and Services
        2.1.4 Medtronic Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 B.Braun Melsungen
        2.2.1 B.Braun Melsungen Details
        2.2.2 B.Braun Melsungen Major Business
        2.2.3 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Product and Services
        2.2.4 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Abbott Laboratories
        2.3.1 Abbott Laboratories Details
        2.3.2 Abbott Laboratories Major Business
        2.3.3 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Product and Services
        2.3.4 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Boston Scientific Corporation
        2.4.1 Boston Scientific Corporation Details
        2.4.2 Boston Scientific Corporation Major Business
        2.4.3 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Product and Services
        2.4.4 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Biosensors International
        2.5.1 Biosensors International Details
        2.5.2 Biosensors International Major Business
        2.5.3 Biosensors International Drug-Eluting Bioabsorbable Stents Product and Services
        2.5.4 Biosensors International Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Terumo Corporation.
        2.6.1 Terumo Corporation. Details
        2.6.2 Terumo Corporation. Major Business
        2.6.3 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Product and Services
        2.6.4 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 MicroPort Scientific Corporation
        2.7.1 MicroPort Scientific Corporation Details
        2.7.2 MicroPort Scientific Corporation Major Business
        2.7.3 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Product and Services
        2.7.4 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 Alvimedica
        2.8.1 Alvimedica Details
        2.8.2 Alvimedica Major Business
        2.8.3 Alvimedica Drug-Eluting Bioabsorbable Stents Product and Services
        2.8.4 Alvimedica Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Biotronik
        2.9.1 Biotronik Details
        2.9.2 Biotronik Major Business
        2.9.3 Biotronik Drug-Eluting Bioabsorbable Stents Product and Services
        2.9.4 Biotronik Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 Elixir Medical Corporation
        2.10.1 Elixir Medical Corporation Details
        2.10.2 Elixir Medical Corporation Major Business
        2.10.3 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Product and Services
        2.10.4 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.11 Innovative Health Technologies
        2.11.1 Innovative Health Technologies Details
        2.11.2 Innovative Health Technologies Major Business
        2.11.3 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Product and Services
        2.11.4 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Drug-Eluting Bioabsorbable Stents Breakdown Data by Manufacturer
    3.1 Global Drug-Eluting Bioabsorbable Stents Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Drug-Eluting Bioabsorbable Stents Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Drug-Eluting Bioabsorbable Stents
    3.4 Market Concentration Rate
        3.4.1 Top 3 Drug-Eluting Bioabsorbable Stents Manufacturer Market Share in 2021
        3.4.2 Top 6 Drug-Eluting Bioabsorbable Stents Manufacturer Market Share in 2021
    3.5 Global Drug-Eluting Bioabsorbable Stents Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Drug-Eluting Bioabsorbable Stents Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global Drug-Eluting Bioabsorbable Stents Market Size by Region
        4.1.1 Global Drug-Eluting Bioabsorbable Stents Sales in Volume by Region (2017-2028)
        4.1.2 Global Drug-Eluting Bioabsorbable Stents Revenue by Region (2017-2028)
    4.2 North America Drug-Eluting Bioabsorbable Stents Revenue (2017-2028)
    4.3 Europe Drug-Eluting Bioabsorbable Stents Revenue (2017-2028)
    4.4 Asia-Pacific Drug-Eluting Bioabsorbable Stents Revenue (2017-2028)
    4.5 South America Drug-Eluting Bioabsorbable Stents Revenue (2017-2028)
    4.6 Middle East and Africa Drug-Eluting Bioabsorbable Stents Revenue (2017-2028)
5 Market Segment by Type
    5.1 Global Drug-Eluting Bioabsorbable Stents Sales in Volume by Type (2017-2028)
    5.2 Global Drug-Eluting Bioabsorbable Stents Revenue by Type (2017-2028)
    5.3 Global Drug-Eluting Bioabsorbable Stents Price by Type (2017-2028)
6 Market Segment by Application
    6.1 Global Drug-Eluting Bioabsorbable Stents Sales in Volume by Application (2017-2028)
    6.2 Global Drug-Eluting Bioabsorbable Stents Revenue by Application (2017-2028)
    6.3 Global Drug-Eluting Bioabsorbable Stents Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
    7.1 North America Drug-Eluting Bioabsorbable Stents Sales by Type (2017-2028)
    7.2 North America Drug-Eluting Bioabsorbable Stents Sales by Application (2017-2028)
    7.3 North America Drug-Eluting Bioabsorbable Stents Market Size by Country
        7.3.1 North America Drug-Eluting Bioabsorbable Stents Sales in Volume by Country (2017-2028)
        7.3.2 North America Drug-Eluting Bioabsorbable Stents Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
    8.1 Europe Drug-Eluting Bioabsorbable Stents Sales by Type (2017-2028)
    8.2 Europe Drug-Eluting Bioabsorbable Stents Sales by Application (2017-2028)
    8.3 Europe Drug-Eluting Bioabsorbable Stents Market Size by Country
        8.3.1 Europe Drug-Eluting Bioabsorbable Stents Sales in Volume by Country (2017-2028)
        8.3.2 Europe Drug-Eluting Bioabsorbable Stents Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales by Type (2017-2028)
    9.2 Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales by Application (2017-2028)
    9.3 Asia-Pacific Drug-Eluting Bioabsorbable Stents Market Size by Region
        9.3.1 Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Drug-Eluting Bioabsorbable Stents Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
    10.1 South America Drug-Eluting Bioabsorbable Stents Sales by Type (2017-2028)
    10.2 South America Drug-Eluting Bioabsorbable Stents Sales by Application (2017-2028)
    10.3 South America Drug-Eluting Bioabsorbable Stents Market Size by Country
        10.3.1 South America Drug-Eluting Bioabsorbable Stents Sales in Volume by Country (2017-2028)
        10.3.2 South America Drug-Eluting Bioabsorbable Stents Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales by Type (2017-2028)
    11.2 Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales by Application (2017-2028)
    11.3 Middle East & Africa Drug-Eluting Bioabsorbable Stents Market Size by Country
        11.3.1 Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Drug-Eluting Bioabsorbable Stents Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
    12.1 Raw Material of Drug-Eluting Bioabsorbable Stents and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Drug-Eluting Bioabsorbable Stents
    12.3 Drug-Eluting Bioabsorbable Stents Production Process
    12.4 Drug-Eluting Bioabsorbable Stents Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Drug-Eluting Bioabsorbable Stents Typical Distributors
    13.3 Drug-Eluting Bioabsorbable Stents Typical Customers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Drug-Eluting Bioabsorbable Stents Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?